NIH launches first U.S. clinical trial of patient-derived stem cell therapy to replace dying cells in retina

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

 

12/16/2019 11:45 AM EST

NEI-led study to test safety of treatment for a form of age-related macular degeneration that currently lacks treatment.

This email was sent to ymilov@gmail.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612 GovDelivery logo